| pubmed-article:11034270 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11034270 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:11034270 | lifeskim:mentions | umls-concept:C0003286 | lld:lifeskim |
| pubmed-article:11034270 | lifeskim:mentions | umls-concept:C0064636 | lld:lifeskim |
| pubmed-article:11034270 | lifeskim:mentions | umls-concept:C0184661 | lld:lifeskim |
| pubmed-article:11034270 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:11034270 | lifeskim:mentions | umls-concept:C0008565 | lld:lifeskim |
| pubmed-article:11034270 | lifeskim:mentions | umls-concept:C2346501 | lld:lifeskim |
| pubmed-article:11034270 | lifeskim:mentions | umls-concept:C0332183 | lld:lifeskim |
| pubmed-article:11034270 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11034270 | pubmed:dateCreated | 2001-1-17 | lld:pubmed |
| pubmed-article:11034270 | pubmed:abstractText | The authors have developed a simple isocratic high-pressure liquid chromatographic (HPLC) assay for the simultaneous determination of lamotrigine and other frequently coadministered antiepileptic drugs in serum samples. Lamotrigine extraction was performed on a reversed-phase Oasis HBL preparation column. The eluates containing butalbital as internal standard were separated with a 7-microm Chromsystems C18 250 x 4.0 mm I.D. reversed-phase column at a temperature of 40 degrees C using a mobile phase consisting of pH 3.8 phosphate-acetonitrile buffer (55:45, v/v), at a flow rate of 0.8 mL/min. Ultraviolet detection was carried out at 210 nm. Measurement of the peak:height ratio allowed quantitative determination of the samples. The method was linear over a concentration range of 0.2 to 20 microg/mL for lamotrigine. Recovery was >90%. Within-day and between-day coefficients of variation ranged from 1.8% to 6.7%. The mean lamotrigine concentration was 8.01 +/- 5.63 microg/mL. After studying sera from 130 patients treated with lamotrigine the authors confirmed that associated antiepileptic therapy affected the serum lamotrigine levels, which were significantly higher in patients under valproic acid treatment. | lld:pubmed |
| pubmed-article:11034270 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11034270 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11034270 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11034270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11034270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11034270 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11034270 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11034270 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11034270 | pubmed:issn | 0163-4356 | lld:pubmed |
| pubmed-article:11034270 | pubmed:author | pubmed-author:ArroyoSS | lld:pubmed |
| pubmed-article:11034270 | pubmed:author | pubmed-author:TorreAA | lld:pubmed |
| pubmed-article:11034270 | pubmed:author | pubmed-author:CorbellaJJ | lld:pubmed |
| pubmed-article:11034270 | pubmed:author | pubmed-author:RodamilansMM | lld:pubmed |
| pubmed-article:11034270 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11034270 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:11034270 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11034270 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11034270 | pubmed:pagination | 621-5 | lld:pubmed |
| pubmed-article:11034270 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:meshHeading | pubmed-meshheading:11034270... | lld:pubmed |
| pubmed-article:11034270 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11034270 | pubmed:articleTitle | Optimized procedure for lamotrigine analysis in serum by high-performance liquid chromatography without interferences from other frequently coadministered anticonvulsants. | lld:pubmed |
| pubmed-article:11034270 | pubmed:affiliation | Toxicology Unit and Neurology Service, Hospital Clínic, Facultat de Medicina, Universitat de Barcelona, Spain. | lld:pubmed |
| pubmed-article:11034270 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11034270 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11034270 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11034270 | lld:pubmed |
